Journey Medical CorporationDERMNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank72
5Y CAGR+119.9%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
+119.9%/yr
Long-term compound
Percentile
P72
Within normal range
vs 5Y Ago
51.4x
Strong expansion
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 17.47% |
| Q2 2025 | 14.23% |
| Q1 2025 | -3.53% |
| Q4 2024 | -6.90% |
| Q3 2024 | -1.52% |
| Q2 2024 | 14.01% |
| Q1 2024 | -14.60% |
| Q4 2023 | -55.83% |
| Q3 2023 | 101.14% |
| Q2 2023 | 40.60% |
| Q1 2023 | -23.51% |
| Q4 2022 | -0.93% |
| Q3 2022 | -11.89% |
| Q2 2022 | -21.48% |
| Q1 2022 | 32.99% |
| Q4 2021 | -10.67% |
| Q3 2021 | 28.27% |
| Q2 2021 | 42.63% |
| Q1 2021 | -21.89% |
| Q4 2020 | 45.26% |
| Q3 2020 | 0.34% |
| Q2 2020 | -11.85% |
| Q1 2020 | 0.00% |
| Q3 2019 | -82.69% |
| Q2 2019 | 2617.99% |
| Q1 2019 | 9.32% |
| Q4 2018 | 212.83% |
| Q3 2018 | -98.17% |
| Q2 2018 | 12970.23% |
| Q1 2018 | -77.74% |
| Q4 2017 | 25.98% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -95.26% |
| Q4 2016 | 18778.99% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |
| Q4 2015 | 0.00% |
| Q3 2015 | 0.00% |